glp 1 hypothyroidism GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Glucagon-like peptide 1 receptor agonist
Description
A recent study from British Columbia, Canada, explored the effects of GLP-1 receptor agonists in nearly 11,000 patients with both autoimmune conditions and diabetes
Two additional Phase 3 oral assets are particularly useful to watch because they represent next entrants rather than franchise conversions: HDM1002 (conveglipron) HDM1002 is being positioned publicly as a selective oral small-molecule GLP-1R agonist for type 2 diabetes and obesity
b Retatrutide is a triple agonist (GLP-1/GIP/glucagon)
Disclosure: Im a paid contributor to NutritionNC.com and was not compensated by Willow for this review
Picardi, A
4 Caro, Rebecca DO
